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ABSTRACT 
The clinical introduction of magnetic resonance imaging guided radiotherapy has prompted 
consideration of the potential impact of the static magnetic field on biological responses to 
radiation. This review provides an introduction to the mechanisms of biological interaction of 
radiation and magnetic fields individually, in addition to a description of the magnetic field 
effects on megavoltage photon beams at the macroscale, microscale and nanoscale arising 
from the Lorentz force on secondary charged particles.  
A relatively small number of scientific studies have measured the impact of combined static 
magnetic fields and ionising radiation on biological endpoints of relevance to radiotherapy. 
Approximately half of these investigations found that static magnetic fields in combination 
with ionising radiation produced a significantly different outcome compared with ionising 
radiation alone. MRI strength static magnetic fields appear to modestly influence the 
radiation response via a mechanism distinct from modification to the dose distribution. This 
review intends to serve as a reference for future biological studies, such that understanding of 
static magnetic field plus ionising radiation synergism may be improved, and if necessary, 
accounted for in magnetic resonance imaging guided radiotherapy treatment planning.  
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INTRODUCTION  
Image-guided radiotherapy (IGRT) aims to minimise uncertainties in treatment delivery 
through the use of medical imaging at frequent intervals throughout the patient’s treatment 
course. One recent IGRT development has been the integration of magnetic resonance 
imaging (MRI) with a radiotherapy treatment machine [1].  
The first patient treatments were recently completed with the Elekta Atlantic MR-Linac [2], a 
device consisting of a 1.5 T Philips MRI system and a 7 MV accelerator. The ViewRay 
MRIdian system (0.35 T MRI and three Co-60 sources) has been used to treat patients since 
2014 [3] and a 6 MV linac version of the MRIdian system was recently introduced [4]. Two 6 
MV MR-Linac systems currently being developed in Australia [5] and Canada [6] feature 1 T 
and 0.5 T MRI systems respectively.  
Starting from current understanding of the individual effects of ionizing radiation and strong 
magnetic field, this review is evaluating the evidence concerning a range of biological effects 
of the combination of static magnetic field (SMF) and ionising radiation (IR) for magnetic 
field strengths and radiation qualities of relevance to MR-guided radiotherapy (MRgRT). 
This will enable an assessment of the likelihood of altered radiobiological response in 
patients treated by MRgRT and will help designing studies to investigate possible synergetic 
effects.  
RADIOBIOLOGY: TARGETED AND NON-TARGETED EFFECTS  
Biological injury resultant from IR exposure has long been understood to be primarily 
mediated by lethal or misrepaired deoxyribonucleic acid (DNA) damage. Such DNA damage 
may lead to loss of a cell’s proliferative capacity, a result seized upon for the treatment of 
cancer with radiation.  
Megavoltage photon beams produce energetic free electrons via interaction with matter, 
which in turn produce a large number of ionisations along their tracks. In the classical 
paradigm, IR is capable of damaging the DNA molecule by two processes; 1. direct action, 
whereby energy is transferred from an incident ionising particle to the DNA molecule, 
resulting in a DNA lesion and 2. indirect action which involves the interaction of an IR-
generated reactive species (e.g. OH produced via radiolysis of water) with DNA, resulting in 
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a DNA lesion. Indirect action accounts for 65% of DNA lesions induced by low linear energy 
transfer (LET) radiation sources such as MV photon beams [7].  
DNA lesions induced by IR can take several forms, such as single DNA strand breaks 
(SSBs), double DNA strand breaks (DSBs) and a variety of base modifications which may 
lead to SSBs and DSBs. The formation of two or more lesions within 10 to 20 base pairs 
located either tandemly or on opposing strands is termed clustered damage, of which DSB is 
an example. For low LET radiation, approximately 30% of the deposited energy yields 
clustered damage [8]. Two DSB repair mechanisms exist; homologous recombination and 
non-homologous end joining. The mechanism underlying the choice of repair pathway is not 
fully understood, but is thought to relate to chromatin complexity in the region of the DSB 
[9].  
Whilst DNA is considered the predominant site of IR-induced lethality, IR has also been 
shown to induce biologically significant changes to cellular lipids and proteins [10].  
Non-targeted effects comprise IR-mediated pathways that lead to biological responses in cells 
other than those irradiated. Growing evidence of such effects in vitro [11] and in vivo [12] 
has challenged the dogma that IR may only elicit a cellular response via energy deposition 
within its nucleus. Increased frequency of phenomena such as chromosomal changes, 
carcinogenesis and cell death have been observed in both the direct descendants of irradiated 
cells (radiation-induced genomic instability) and cells that have communicated with 
irradiated cells (radiation-induced bystander effects) [13, 14].  
MAGNETOBIOLOGY  
Three well-established, experimentally verified classes of physical interaction of SMF with 
biological systems exist [15, 16]:  
1. Electrodynamic interactions. Electric potentials and current induced by interaction of 
magnetic dipoles with SMF. The Lorentz force, exerted perpendicularly to the 
direction of the magnetic field 𝑩 and the velocity of moving charges 𝒗 is associated 
with an electric field 𝑬 =  𝒗 ×  𝑩. The separation of charged particles (e.g. 
electrolytes in the blood) due to the electric field results in the establishment of 
electrical potentials. 
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2. Magnetomechanical effects. Torque and forces which may give rise to translational 
motion exerted on materials due to SMF, associated with mechanical stress and strain. 
An object with magnetic susceptibility 𝜒 placed in a magnetic field gradient 
experiences a force proportional to 𝜒 and the gradient of 𝐵2. The force is towards the 
field maximum for paramagnetic (positive 𝜒) objects and in the opposite direction for 
diamagnetic (negative 𝜒) objects. Materials with anisotropic susceptibility experience 
SMF-induced torque towards the orientation which represents a minimum energy 
state. Additionally, the retarding force on blood flow arising from the influence of the 
Lorentz force on moving electrolytes may be classified as a magnetomechanical 
effect.  
3. Effects on electron spin states of reaction intermediates. Alteration to rates of 
chemical reactions involving free radical intermediates via the influence of SMF on 
the electron spin states of the radicals. SMF impacts the rate of intersystem crossing 
between the singlet and triplet spin states via mechanisms originating from the 
splitting of Zeeman energy levels [17].   
The World Health Organization (WHO) reviewed the evidence concerning biological effects 
of 0 T to 14 T SMF, collecting in vitro, animal, laboratory human and epidemiological 
studies [15].  
A wide range of biological end-points have been studied in mammalian cells, including; cell 
orientation and morphology, cell metabolic activity, cell growth, cell cycle distribution, cell 
membrane physiology, gene expression and genotoxicity. The influence of strong SMF 
(greater than 1 T) on the orientation of cells in vitro via magneto-mechanical effects is well 
documented [15] whereas evidence for the SMF dependence of other end-points in vitro is 
less clear. For almost all of the end-points studied, SMF has been shown to either have a 
positive, negative or null effect suggesting a strong dependency upon the combination of the 
exposure conditions (field strength, time) and biological system under investigation.  
Many animals are susceptible to the geomagnetic field and utilise this ability for their 
navigation [18]. In the case of migratory birds, two distinct magnetoreceptive mechanisms 
appear to take place; a SMF dependent radical-pair mechanism involving a photoactive 
protein in the eye [19] and magnetite-based receptors in the beak susceptible to SMF torque 
[20]. Some in vivo studies have demonstrated that strong SMF (0.1 T to 1 T) generates 
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measurable flow potentials around the heart and major blood vessels of animals and humans, 
however the physiological impacts of such potentials are unclear [15]. Based on those current 
in vivo and in vitro evidences, the World Health Organization concluded that other 
hypotheses regarding SMF effects in animals and humans, such as stimulated bone growth, 
endocrine responses, blood pressure, microcirculation, haematopoiesis, carcinogenesis, 
reproduction and development were not well supported by reproducible evidence [15].  
MAGNETIC FIELD EFFECTS ON MV PHOTON BEAM DOSE DISTRIBUTIONS  
The recent interest in MRgRT has motivated study of the impact of the strong SMF (𝐵 = 0.35 
T to 1.5 T) on the radiation dose distribution to account accordingly for effects during 
radiotherapy treatment planning [21–29]. However, interest in this question pre-dates MRI, 
as researchers as early as 1950 considered whether magnetic fields could be exploited to 
confine radiotherapy treatment fields, minimising healthy tissue damage [30–39].  
A particle with charge 𝑞 travelling within a magnetic field 𝑩 with velocity 𝒗 will experience 
the magnetic Lorentz force 𝑭 perpendicular to both the 𝒗 and 𝑩:  
 𝑭 =  𝑞𝒗 ×  𝑩 (1) 
For radiotherapy MV photon beams, this has implications for trajectories of secondary 
charged particles generated in the patient via photoelectric effect, Compton scattering and 
pair production. In vacuum, a uniform magnetic flux density of magnitude 𝐵 causes particles 
to spiral with gyration radius:  
 𝑟𝑔 =
𝑚𝑣⊥
|𝑞|𝐵
 
(2) 
with 𝑚 the particle mass, 𝑣⊥ its velocity perpendicular to the magnetic field and |𝑞| the 
charge magnitude. However, in media, although the particle experiences the Lorentz force, 
the regularity of its helical track structure is broken by discrete scattering processes. Energy 
losses via scattering events leads to an overall reduction in 𝑟𝑔, yielding a spiralling particle 
track. As electrons exit the patient into air, their mean free path becomes long compared to 𝑟𝑔, 
allowing the helical path to be traversed with minimal interaction. This path returns electrons 
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to the exit surface of the patient (electron return effect), leading to a significantly enhanced 
dose in the region.  
Regarding macrodosimetry, Geant4 [40] Monte Carlo (MC) simulation of 1 × 1 and 5 × 5 
cm2 fields of an Elekta SLi 20 modelled 6 MV photon spectrum incident upon a water 
phantom in transverse 𝐵 = 1.5 T produced asymmetric penumbra and a similar central axis 
depth dose profile to 𝐵 = 0 T, shifted by 5 mm towards the entrance surface under the 
magnetic field [21]. Although the field dimensions (50 % isodose) were unaffected, the entire 
field was shifted by approximately 0.7 mm in the direction perpendicular to the SMF and the 
beam axis [21]. Macrodosimetric effects are generally increased at higher magnetic field 
strengths [24].  
In the presence of heterogeneities, the impact of the magnetic field is significant. The 
electron return effect (ERE) was demonstrated by MC simulation of a 6 MV linac beam 
incident upon heterogeneous phantoms comprised of water and air regions with transverse 𝐵 
= 1.5 T [22]. An increased exit dose of order 40 % was observed. In addition to the exit 
surface, ERE also has profound implications for air cavities and low density tissues such as 
lung [25]. The problem of ERE exit dose enhancement was largely mitigated by using 
opposing beams [23] and clinically acceptable MR-Linac treatment plans are attainable with 
intensity modulated radiotherapy (IMRT) inverse planning for dose optimisation [26, 41].  
At the microdosimetric level, it is pertinent to consider whether SMF significantly influences 
radiation quality and hence relative biological effectiveness (RBE). Kirkby et al. [42] used 
the MC code PENELOPE to study the energy deposition spectra within a microscopic target 
(10 μm diameter water sphere) in the presence of SMF up to 1000 T. Mono-energetic 
electron beams (0.01, 0.025, 0.1 and 1 MeV) and secondary electron spectra obtained on the 
central axis, 1.5 cm to 3.5 cm deep in water for a simulated Varian 6 MV photon source were 
studied. The track-averaged lineal energy and dose-averaged lineal energy were virtually 
identical at 𝐵 = 1.5 T (both parallel and transverse orientations) to 𝐵 = 0 T. The change in 
dose-averaged lineal energy relative to the 𝐵 = 0 T case only exceeded 2 % at 70 T 
(transverse orientation).  
It is generally accepted that cell lethality is linked to the complexity of DNA damage. The 
MC code Geant4-DNA was used to study the impact of transverse SMF (up to 14 T) on 
electron track structure in order to determine the probability distribution of the formation of 
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nanometric ionisation clusters of a given size [43]. The number of ionisation events per 
incident primary particle within two nanoscale water targets representing a DNA segment 
and nucleosome were recorded for monoenergetic electron pencil beams (200 eV to 10 keV). 
The mean ionisation cluster size and the probability of formation of at least two ionisations 
per incident particle inside the DNA segment deviated minimally from the 𝐵 = 0 T case for 
all field strengths and primary electron energies studied. Application of the 𝐵 = 1.5 T field 
led to a 2 % increase in the probability of at least two ionisations occurring within the DNA 
segment by 5 keV electrons. However, for a polyenergetic electron spectrum, no significant 
difference in clustered damage formation would be expected with application of a magnetic 
field [43]. A follow-up study found that SMF (up to 10 T) had no significant influence on 
double strand formation probability for Geant4-DNA simulated electron (200 eV – 10 keV), 
proton (300 keV – 30 MeV) and alpha particle (1 MeV – 9 MeV) track structures [44]. Only 
direct damage to DNA was considered in these works; further simulation incorporating 
radiochemical transport, including the effect of magnetic fields on such processes is 
necessary [43]. Moreover, there is limited evidence to support the general assumption in MC 
studies that SMF does not alter interaction cross sections, only particle transport. However, 
Szymanowski et al. reported that the partial alignment of water molecules caused by 1.5 T 
SMF had negligible impact on differential cross sections for electron scattering relative to no 
field [45]. 
BIOLOGICAL EFFECTS OF COMBINED IONISING RADIATION AND STRONG 
STATIC MAGNETIC FIELD EXPOSURE  
While there have been a wealth of studies examining the biological effects of ionising 
radiation and SMF individually, relatively few have investigated the effects of both agents 
combined (Table 1).  
The earliest study retrieved reported the impact of strong SMF on the mortality of Drosphila 
melanogaster eggs irradiated with 150 kVp X-rays [46]. SMF alone did not significantly 
influence the ratio of hatched eggs, however when SMF was applied during irradiation the 
egg mortality rate was increased in 30 out of 39 experiments. SMF during irradiation was 
associated with a mean increase in mortality rate of 16.8 ± 3.4 %. Subsequent studies of 
Drosophila melanogaster concluded that SMF during irradiation did not affect production of 
sex-linked recessive lethals in mature spermatozoa [48, 49] nor mean life span for flies 
treated with strong SMF for 30 minutes post-irradiation [47].  
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Barnothy [50] investigated the effect of SMF pre-treatment (14 days) on the mortality of 
whole body irradiated mice. A mortality reduction of 26.7 ± 3.2 % was observed for SMF 
treated mice compared with those exposed to a dummy magnet, possibly due to SMF 
stimulated leukocytosis which counterbalanced radiation-induced leukopenia [50]. A separate 
study reported a deleterious effect of SMF in rats that received targeted liver doses of 60 Gy 
in 9 daily fractions [52]. Serum concentrations of aminotransferases and total hemolytic 
complement were used to assess liver damage; significantly greater elevation in serum 
enzyme levels was produced by irradiation with SMF than by irradiation in the absence of the 
field. A similar elevation of serum aminotransferases (from 70 days post SMF treatment) was 
also observed in rats not exposed to ionising radiation relative to controls, prompting the 
conclusion that the enhanced liver damage observed in SMF plus ionising radiation exposed 
rats may be due to the addition of separate damage mechanisms rather than a mechanism 
arising uniquely from SMF plus ionising radiation synergism [52].   
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Table 1. Summary of investigations into the biological effects of combined static magnetic fields and ionising radiation. Static magnetic field 
exposure times are stated in brackets. Ionising radiation nominal energies were listed if available and doses were delivered in a single fraction unless 
otherwise stated. Significance result noted if any SMF + IR exposure conditions produced a statistically significant difference (P < 0.05) in the 
biological endpoint measured from equivalent IR alone, as reported by the authors. Abbreviation IR denotes ionising radiation exposure. 
Reference   Biological 
specimen  
Static Magnetic Field Ionising radiation Endpoint studied Effect of SMF on 
IR response  
Forssberg [46]  Drosophila 
melanogaster  
0.6 T during IR 150 kVp X-rays, 1.65 Gy  Egg mortality rate  Increased mortality 
Close and Beischer 
[47]  
Drosophila 
melanogaster  
1 T post-IR (30 mins)  X-rays, 36.9 Gy  Sex-linked recessive lethals None 
Life span None 
Mittler [48]  Drosophila 
melanogaster  
1.1 T during IR  200 kVp X-rays, 33 Gy  Sex-linked recessive lethals  None 
Kale and Baum 
[49]  
Drosophila 
melanogaster  
3.7 T during IR  Cf-252 neutron and gamma, 1.8 
Gy to 5.8 Gy  
Sex-linked recessive lethals  None 
Barnothy [50]  Mouse  0.42 T pre-IR (14 days)  Co-60 gamma, 8 Gy  Mortality Decreased mortality 
Amer [51]  Tribolium 
confusum  
0.22 T, 0.36 T, 0.97 T 
post-IR (7 days)  
250 kVp X-rays, 12 Gy Wing abnormalities Decreased 
abnormalities 
Wordsworth [52]  Rat liver (in vivo) 0.6 T during IR  240 kVp X-rays, 60 Gy in 9 
fractions  
Serum component 
levels associated with liver 
damage 
Increased serum 
enzyme levels 
Tinney and 
Aldridge [53]  
Saccharomyces 
cerevisiae  
0.17 T during IR  200 kVp X-rays, dose not 
reported  
Clonogenic survival Decreased survival 
Chen et al. [54]  Saccharomyces 
cerevisiae  
0.78 T during IR  Co-60 gamma, 300 Gy  Clonogenic survival None 
Rockwell [55]  Mouse mammary 
tumour cells 
(EMT6)  
0.14 T during IR 120 kVp X-rays, up to 12 Gy Clonogenic survival   None 
0.14 T post-IR (up to 5 
h)  
120 kVp X-rays, 10 Gy in 2 
fractions  
Recovery from sub-lethal 
damage 
None 
0.14 T post-IR (up to 25 
h)  
120 kVp X-rays, 10 Gy  Recovery from potentially-
lethal damage 
None 
Nath et al. [56]  Chinese hamster 
lung cells (CCL16)  
2 T during IR  30 MV X-rays, up to 30 Gy Clonogenic survival  None 
30 MV X-rays, up to 30 Gy in 
2 fractions  
Recovery from sub-lethal 
damage  
None 
Ngo et al. [57]  Chinese hamster 
lung cells (V79)  
0.75 T during IR  25 MeV, 43 MeV neutrons, up 
to 30 Gy  
Clonogenic survival None 
DNA synthesis  None 
0.75 T post-IR (1 h)  Clonogenic survival None 
Nakahara et al. [58]  Chinese hamster 
ovary cells (CHO-
K1)  
1T, 10 T post-IR (18 h)  X-rays, up to 4 Gy  Micronucleus formation  Increased 
micronucleus 
formation 
Sarvestani et al. 
[59]  
Rat bone marrow 
stem cells  
0.015 T post-IR (5 h)  140 kVp X-rays, 0.5 Gy  Cell cycle distribution Increased G2/M 
fraction 
Politański et al. 
[60]  
Ratlymphocytes  0.005 T post-IR (up to 2 
h)  
X-rays, 3 Gy  Intracellular reactive oxygen 
species  
Increased reactive 
oxygen species  
Takatsuji et al. [61]  Human peripheral 
blood lymphocytes  
1.1 T during IR  4.9 MeV protons and 23 MeV 
alpha particles, up to 3Gy  
Dicentric chromosome rate  Increased 
chromosome 
aberrations 
Kubinyi et al. [62]  Human leukocytes 
in blood  
0.16 T (homogeneous) or 
inhomogeneous SMFs 
pre or post-IR (24 h)  
Co-60 gamma, 4 Gy  DNA damage  None (pre)   
Decreased DNA 
damage (post) 
Feng et al. [63]  Human lung 
adenocarcinoma 
cells (A549)  
0.5 T post-IR (1 h)  X-rays, up to 10 Gy  Clonogenic survival Decreased survival 
Apoptosis Increased apoptosis 
Teodori et al. [64]  Human primary 
glioblastoma cells  
0.08 T pre-IR (0 or 6 h) 
plus post-IR (up to 20 h)  
250 kVp X-ray, 5 Gy  DNA damage Decreased DNA 
damage 
Mitochondrial membrane 
potential  
Decreased loss of 
mitochondrial 
membrane potential 
Wang et al. [65]   Human head/neck 1.5 T during IR   6 MV X-rays, up to 8 Gy in 1, Clonogenic survival   None 
  10 
and lung cancer 
cells (H460, 
H1299, HN5, 
UMSCC47)   
3 or 4 fractions   
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Amer [51] studied the effect of strong SMF exposure for a duration of 7 days immediately 
post-irradiation on wing development in Tribolium confusum. SMF conferred a protective 
effect, yielding significantly fewer wing abnormalities in radiation exposed animals. 
Temperature and radiation dose were found to impact the magnitude of the SMF effect, 
which comprised a 11 % to 36 % reduction in wing anomaly occurrence across the various 
experiments reported.  
Two studies of saccharomyces cerevisiae (yeast) have provided limited evidence for an 
impact of SMF during X-ray irradiation on clonogenic survival [53, 54]. Tinney and Aldridge 
[53] observed 27 % to 33 % fewer surviving colonies in samples exposed to 0.17 T SMF 
during irradiation, however full details of the authors’ methods were not published. In a work 
which carefully accounted for dose distribution modifications of a 0.78 T SMF during Co-60 
irradiation, Chen et al. [54] found that in five out of seven experiments the null hypothesis 
(i.e. no effect of SMF) could not be rejected (t-test P > 0.05). SMF was associated with a 
modest reduction in clonogenic survival of 3.9 ± 2.7 % [54].  
Motivated by theoretical work on the potential for SMF confinement of radiotherapy beams 
[32], three studies assessed the impact of various combinations of SMF strengths, radiation 
qualities and mammalian in vitro models [55–57] (see Table 1). All concluded that survival 
curves for cells irradiated with and without simultaneous SMF were indistinguishable. 
Application of SMF during incubation post-irradiation did not influence recovery from sub-
lethal or potentially lethal damage. Nath et al. [56] performed experiments with Chinese 
hamster lung cells irradiated in either aerated or hypoxic conditions. Non-parametric analysis 
[66] yielded a dose modifying factor of unity for SMF for both the normoxic and hypoxic 
experiments. Ngo et al. [57] reported that the DNA synthetic rate was unaffected by the 
presence of SMF during fast neutron irradiation. However, DNA synthesis was slightly 
suppressed by longer SMF durations in non-irradiated cells, e.g. by approximately 10 % at 3 
hours SMF exposure.  
Nakahara et al. [58] investigated whether incubation in a strong SMF (1 T and 10 T) 
influenced the number of micronuclei produced in Chinese hamster ovary cells exposed to X-
rays. Micronuclei frequency was unaltered by SMF alone. A small yet significant increase in 
the micronuclei frequency of approximately 10 % was observed in cells incubated in a 10 T 
SMF for 18 hours following 4 Gy irradiation (P < 0.05, Fisher protected least significant 
difference test). For all other combinations of SMF strength and radiation dose, no significant 
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difference in micronuclei frequency due to SMF was observed. This evidence suggests that 
10 T SMF, although not in itself genotoxic, may inhibit the repair of DNA damage or 
intensify X-ray induced mitotic spindle apparatus damage [58].  
Sarvestani et al. [59] studied the cell cycle distributions of rat bone marrow stem cells 
irradiated with orthovoltage X-rays prior to incubation in either 0.015 T SMF or the 
geomagnetic field alone (60 μT). Flow cytometry analysis revealed that 0.015 T SMF 
exposure increased the percentage of cells in the G2/M phase following irradiation from 
14.35 ± 0.13 % to 15.30 ± 0.57 % (P < 0.05 for Student’s t-test) [59]. G2/M arrest is 
associated with DNA damage; hence this result suggests that moderate SMF may slightly 
enhance radiation induced damage. The authors posit SMF influence on electronic spin states 
(thereby altering kinetics of chemical reactions involving radical pairs) as the presumptive 
mechanism [59]. This hypothesis was supported by the work of Politański et al. [60] in which 
measurements of intracellular reactive oxygen species (ROS) were performed in rat 
lymphocytes in vitro, subsequent to weak SMF exposure (5 mT). SMF was associated with 
statistically significant increases in dichlorofluorescein probe fluorescence (proportional to 
the ROS level) both with and without X-ray radiation (Tukey’s post hoc test P < 0.05) [60].  
Two studies of human white blood cells in vitro have provided additional evidence of a small 
influence of SMF on radiation-induced DNA damage [61, 62]. The frequency of 
chromosome aberrations in human peripheral blood lymphocytes exposed simultaneously to 
1.1 T SMF and ionising radiation (4.9 MeV protons and 23 MeV alpha particles) was subtly 
increased [61]. Regression analysis of dicentric data fitted to a linear quadratic model yielded 
a significant difference in α coefficients (associated with the one-track radiation damage 
component) for 1.1 T SMF during proton beam irradiation compared with irradiation in the 
absence of SMF (P < 0.05). For the alpha particle irradiations, the significance criterion was 
not met. The authors suggested that SMF modulation of charged particle tracks via the 
Lorentz force resulted in an effective increase in the linear energy transfer, with the effect 
more pronounced for the more sparsely ionising 4.9 MeV proton beam; however, other 
possible magnetobiological interaction mechanisms were not accounted for [61]. Kubinyi et 
al. [62] assessed the impact on DNA damage of 0.16 T homogeneous SMF and a range of 
SMF gradients (47.7, 1.2, or 0.3 T/m) applied either before or after Co-60 irradiation of 
human leukocytes in their intact micro-environment in the blood. DNA damage, measured 
via single-cell gel electrophoresis (comet assay), was significantly reduced due to 4 h 0.16 T 
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homogeneous SMF incubation post-irradiation compared with no SMF (P < 0.05). Cells 
incubated in the 0.012 T, 1.2 T/m gradient SMF post-irradiation exhibited a significant 
increase in DNA damage after 1 h. Besides these two anomalies, no significant difference in 
DNA damage was observed relative to SMF non-exposed samples at all other post-irradiation 
incubation time points and SMF strengths [62].  
In the last five years, three studies have been published on the topic of combined SMF and 
ionising radiation exposure in human cancer in vitro models [63–65]. Viability of lung 
adrenocarcinoma cells (cell line A549) treated with 0.5 T SMF alone for 1 h to 4 h was 
significantly inhibited by approximately 10 % relative to untreated cells (P < 0.05) [63]. 
Gene chip analysis revealed that SMF exposure of 1 h produced alterations in gene 
expression associated with the promotion of cell cycle arrest and apoptosis. A549 clonogenic 
survival following X-ray irradiation was significantly impaired in cells exposed to SMF (P < 
0.05), for example the survival fraction at 10 Gy was 0.24 for 𝐵 = 0 T and 0.02 for 𝐵 = 0.5 T. 
Flow cytometry analysis linked SMF exposure with an increase in the proportion of cells in 
phase G2 and M, the most radiosensitive phases, suggesting that SMF may act to 
radiosensitize A549 cells by influencing cell cycle progression via an unidentified interaction 
mechanism [63]. Teodori et al. [64] studied the impact of 0.08 T SMF in combination with 
orthovoltage X-ray irradiation on DNA damage (comet assay) and mitochondrial membrane 
potential (JC-1 probe) in human primary glioblastoma cells in vitro. SMF exposure (24 h) 
without irradiation was associated with a significant increase in DNA damage (P < 0.01) 
[64], which concords with the SMF-related viability reduction observed by Feng et al. [63]. 
Intriguingly, glioblastoma DNA damage was significantly reduced by 6 h and 20 h SMF 
exposure post-irradiation (P < 0.001), while the inclusion of an additional 6 h SMF pre-
treatment did not impact this result [64]. X-ray induced loss of mitochondrial membrane 
potential was diminished by exposure to SMFs during recovery, suggesting a potential link 
between the protection of mitochondria by SMF (possibly via SMF perturbation of the 
electron transport chain in mitochondria) and a reduction in radiation-induced genotoxicity 
[64].  
The only study to have featured an MR-Linac (1.5 T SMF, 6 MV X-rays) was performed by 
Wang et al. [65]. Two human head and neck cancer and two lung cancer cell lines were 
studied in vitro. Robust dosimetry and the use of a cell irradiation jig to ensure high dose 
uniformity to the cells in the presence of SMF were strengths of this work. Exposure 
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conditions were chosen to mimic those experienced by radiotherapy patients, i.e. a series of 
relatively short (15 min) daily sessions. Cell survival was unaffected by SMF alone and all 
survival curves were indistinguishable for irradiations by MR-Linac or conventional 6 MV 
linac. SMF did not significantly impact survival whether treatment was delivered in single or 
multiple fractions [65]. However, the failure of the study to reproduce well-established 
differences in survival in response to dose fractionation without SMF casts doubt upon its 
ability to detect small differences caused by SMF.  
DISCUSSION AND CONCLUSION  
The classical paradigm of radiation-induced biological damage posits DNA as the primary 
site of interaction. MC track structure studies have shown that MRI strength SMF has 
negligible impact on radiobiologically important microdosimetric [42] and nanodosimetric 
[43, 44] quantities. Yet approximately half of the papers comprising the scientific literature 
reported statistically significant difference in the biological end-point measured when SMF 
was combined with ionising radiation relative to ionising radiation exposure alone.  
There are several possible explanations for this disparity. Many of the studies involving 
simultaneous SMF and ionising radiation exposure lacked thorough descriptions of radiation 
dosimetry or tests to characterise the macroscopic dose distribution to which biological 
samples were exposed, with and without simultaneous SMF. Air regions and other 
heterogeneities in proximity to biological material may give rise to ERE-related local dose 
enhancement when SMF is applied. Furthermore, the response of radiation detectors (most 
significantly ionisation chambers) is known to vary with magnetic field strength due to the 
Lorentz force on electrons within the active volume [67], an effect which must be accounted 
for in order to accurately calibrate the radiation output. Differences in the experimental set-up 
and hence in the influence of SMF on the delivered radiation doses may be a contributing 
factor to the contradictory results reported in the literature. It is recommended for future 
studies that tests are included to confirm both the absolute dose and dose uniformity across 
the biological sample, with and without SMF applied, such that any differences may be taken 
into account when evaluating the impact of SMF.  
The absence of SMF-induced changes to the yield and complexity of direct DNA damage 
produced by ionising radiation [42–44] at field strengths in the range utilised in relevant 
biological studies in the literature (Table 1) suggests that an alternative mechanism is 
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responsible for the SMF-related modification to radiobiological injury. This is supported by 
studies in which the application of SMF before or after irradiation produced a significant 
effect versus no SMF, thus removing possible changes to the macroscopic dose distribution 
as a potential variable. In such cases, it can only be inferred that SMF elicits a biological 
response which alters the way in which the system responds to radiation injury. The current 
evidence is insufficient to allow conclusion of the mechanism(s) by which this occurs, 
however the following hypotheses may be considered in future studies: 1. SMF modifies one 
or more steps in the DNA damage response, 2. SMF influences the yield or lifetime of ROS 
responsible for indirect DNA damage, 3. SMF influences inter-cellular signalling implicated 
in non-targeted radiation-induced effects.  
In vitro investigations utilising cells cultured in monolayers represent the majority of the 
scientific literature on this topic (Table 1). Emerging evidence suggests that cells cultured 
using three-dimensional (3D) tissue engineering constructs better reflect many in vivo 
features, such as cell-cell interactions, morphology and the development of 
microenvironmental niches [68]. Radiation response differs significantly in cells cultured in 
3D systems compared with monolayers [69, 70]. The effect of combined SMF and ionising 
radiation in 3D cell cultures has not yet been investigated.  
It should be noted that in the majority of studies presented in Table 1, the magnitude of any 
observed difference in the measured biological endpoint for SMF plus ionising radiation 
relative to ionising radiation alone was modest. However, the divergent literature on the topic 
highlights an important gap in understanding, i.e. the possibility of ionising radiation and 
SMF synergism involving a mechanism other than modification to radiation track structure. 
Further studies incorporating robust radiation dosimetry and 3D cell culture systems are 
needed to supplement the literature on the topic, such that underlying mechanism(s) may be 
elucidated and any impact of SMF on radiation treatment response accounted for during 
MRgRT.  
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